TCG Crossover Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

TCG Crossover Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-253,069	Closed	-$2.6M	–	28
2023 Q2	$2.6M	Hold	253,069	–	–	0.43%	22
2023 Q1	$1.95M	Hold	253,069	–	–	0.38%	22
2022 Q4	$1.86M	Sell	253,069 -1,500	-0.6%	-$9.59K	0.33%	20
2022 Q3	$1.83M	Sell	254,569 -323,691	-56%	-$2.67M	0.55%	20
2022 Q2	$4.92M	Sell	578,260 -455,962	-44%	-$3.93M	2.09%	16
2022 Q1	$9.28M	Sell	1,034,222 -135,990	-12%	-$1.18M	3.72%	11
2021 Q4	$16.2M	Buy	+1,170,212	New	+$14.5M	7.59%	5

Other funds holding ALPN

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return